The economic burden of cancer in Korea in 2002

S. G. Kim, M. I. Hahm, K. S. Choi, N. Y. Seung, H. R. Shin, E. C. Park

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Cancer is the leading cause of death and one of the most significant healthcare expenses in Korea. The purpose of this study was to estimate the economic burden of cancer on Korean society. We studied the medical, non-medical, morbidity and mortality costs related to cancer treatment, lost productivity and premature death. Healthcare claims for 2002 obtained from the Health Insurance Review Agency were used to estimate medical expenditures; these were linked with the Korean Central Cancer Registry database to identify cancer patients. The number of deaths used to estimate mortality costs was obtained from the Annual Report of Mortality from the National Statistics Office of Korea. Moreover, data from the Korean National Statistics Office and Ministry of Labor were used to calculate life expectancy at the age of death, labour force participation, and average age- and gender-specific earnings. In 2002, the estimated total economic cost of cancer amounted to $9.4 billion (1.72% of GDP) at a 3% discount rate. Medical care costs amounted to 13.7% of total costs, non-medical costs 6.5%, morbidity costs 14.5%, and mortality costs accounted for 65.3%. Increased prevention, earlier diagnosis, new therapies and effective cancer control policies are needed to reduce the economic burden of cancer in Korea.

Original languageEnglish
Pages (from-to)136-144
Number of pages9
JournalEuropean Journal of Cancer Care
Volume17
Issue number2
DOIs
Publication statusPublished - 2008 Mar 1

Fingerprint

Korea
Economics
Costs and Cost Analysis
Neoplasms
Mortality
Morbidity
Delivery of Health Care
Annual Reports
Premature Mortality
Second Primary Neoplasms
Health Insurance
Health Expenditures
Life Expectancy
Health Care Costs
Registries
Early Diagnosis
Cause of Death
Databases

All Science Journal Classification (ASJC) codes

  • Oncology

Cite this

Kim, S. G. ; Hahm, M. I. ; Choi, K. S. ; Seung, N. Y. ; Shin, H. R. ; Park, E. C. / The economic burden of cancer in Korea in 2002. In: European Journal of Cancer Care. 2008 ; Vol. 17, No. 2. pp. 136-144.
@article{8be1a83861c542bc820a6939c8f48827,
title = "The economic burden of cancer in Korea in 2002",
abstract = "Cancer is the leading cause of death and one of the most significant healthcare expenses in Korea. The purpose of this study was to estimate the economic burden of cancer on Korean society. We studied the medical, non-medical, morbidity and mortality costs related to cancer treatment, lost productivity and premature death. Healthcare claims for 2002 obtained from the Health Insurance Review Agency were used to estimate medical expenditures; these were linked with the Korean Central Cancer Registry database to identify cancer patients. The number of deaths used to estimate mortality costs was obtained from the Annual Report of Mortality from the National Statistics Office of Korea. Moreover, data from the Korean National Statistics Office and Ministry of Labor were used to calculate life expectancy at the age of death, labour force participation, and average age- and gender-specific earnings. In 2002, the estimated total economic cost of cancer amounted to $9.4 billion (1.72{\%} of GDP) at a 3{\%} discount rate. Medical care costs amounted to 13.7{\%} of total costs, non-medical costs 6.5{\%}, morbidity costs 14.5{\%}, and mortality costs accounted for 65.3{\%}. Increased prevention, earlier diagnosis, new therapies and effective cancer control policies are needed to reduce the economic burden of cancer in Korea.",
author = "Kim, {S. G.} and Hahm, {M. I.} and Choi, {K. S.} and Seung, {N. Y.} and Shin, {H. R.} and Park, {E. C.}",
year = "2008",
month = "3",
day = "1",
doi = "10.1111/j.1365-2354.2007.00818.x",
language = "English",
volume = "17",
pages = "136--144",
journal = "European Journal of Cancer Care",
issn = "0961-5423",
publisher = "Wiley-Blackwell",
number = "2",

}

The economic burden of cancer in Korea in 2002. / Kim, S. G.; Hahm, M. I.; Choi, K. S.; Seung, N. Y.; Shin, H. R.; Park, E. C.

In: European Journal of Cancer Care, Vol. 17, No. 2, 01.03.2008, p. 136-144.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The economic burden of cancer in Korea in 2002

AU - Kim, S. G.

AU - Hahm, M. I.

AU - Choi, K. S.

AU - Seung, N. Y.

AU - Shin, H. R.

AU - Park, E. C.

PY - 2008/3/1

Y1 - 2008/3/1

N2 - Cancer is the leading cause of death and one of the most significant healthcare expenses in Korea. The purpose of this study was to estimate the economic burden of cancer on Korean society. We studied the medical, non-medical, morbidity and mortality costs related to cancer treatment, lost productivity and premature death. Healthcare claims for 2002 obtained from the Health Insurance Review Agency were used to estimate medical expenditures; these were linked with the Korean Central Cancer Registry database to identify cancer patients. The number of deaths used to estimate mortality costs was obtained from the Annual Report of Mortality from the National Statistics Office of Korea. Moreover, data from the Korean National Statistics Office and Ministry of Labor were used to calculate life expectancy at the age of death, labour force participation, and average age- and gender-specific earnings. In 2002, the estimated total economic cost of cancer amounted to $9.4 billion (1.72% of GDP) at a 3% discount rate. Medical care costs amounted to 13.7% of total costs, non-medical costs 6.5%, morbidity costs 14.5%, and mortality costs accounted for 65.3%. Increased prevention, earlier diagnosis, new therapies and effective cancer control policies are needed to reduce the economic burden of cancer in Korea.

AB - Cancer is the leading cause of death and one of the most significant healthcare expenses in Korea. The purpose of this study was to estimate the economic burden of cancer on Korean society. We studied the medical, non-medical, morbidity and mortality costs related to cancer treatment, lost productivity and premature death. Healthcare claims for 2002 obtained from the Health Insurance Review Agency were used to estimate medical expenditures; these were linked with the Korean Central Cancer Registry database to identify cancer patients. The number of deaths used to estimate mortality costs was obtained from the Annual Report of Mortality from the National Statistics Office of Korea. Moreover, data from the Korean National Statistics Office and Ministry of Labor were used to calculate life expectancy at the age of death, labour force participation, and average age- and gender-specific earnings. In 2002, the estimated total economic cost of cancer amounted to $9.4 billion (1.72% of GDP) at a 3% discount rate. Medical care costs amounted to 13.7% of total costs, non-medical costs 6.5%, morbidity costs 14.5%, and mortality costs accounted for 65.3%. Increased prevention, earlier diagnosis, new therapies and effective cancer control policies are needed to reduce the economic burden of cancer in Korea.

UR - http://www.scopus.com/inward/record.url?scp=39749113078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39749113078&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2354.2007.00818.x

DO - 10.1111/j.1365-2354.2007.00818.x

M3 - Article

C2 - 18302650

AN - SCOPUS:39749113078

VL - 17

SP - 136

EP - 144

JO - European Journal of Cancer Care

JF - European Journal of Cancer Care

SN - 0961-5423

IS - 2

ER -